These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26165121)

  • 1. [Protective Activity of Prion Protein Fragments after Immunization of Annimals with Experimentally Induced Alzheimer's Disease].
    Volpina OM; Volkova TD; Medvinskaya NI; Kamynina AV; Zaporozhskaya YV; Aleksandrova IJ; Koroev DO; Samokhin AN; Nesterova IV; Deygin VI; Bobkova NV
    Bioorg Khim; 2015; 41(2):145-53. PubMed ID: 26165121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization witha synthetic fragment 155-164 of neurotrophin receptor p75 prevents memory loss and decreases beta-amyloid level in mice with experimentally induced Alzheimer's disease].
    Vol'pina OM; Medvinskaia NI; Kamynina AV; Zaporozhskaia IaV; Aleksandrova IIu; Koroev DO; Samokhin AN; Volkova TD; Arsen'ev AS; Bobkova NV
    Bioorg Khim; 2014; 40(4):451-7. PubMed ID: 25898755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies to synthetic fragment 95-123 of the prion protein protect neurons and astrocytes from beta-amyloid toxicity].
    Kamynina AV; Filatova MP; Koroev DO; Abramov AIu; Vol'pina OM
    Bioorg Khim; 2013; 39(2):131-40. PubMed ID: 23964513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity of beta-amyloid and prion peptides.
    Forloni G
    Curr Opin Neurol; 1996 Dec; 9(6):492-500. PubMed ID: 9007411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fragment of Receptor for Advanced Glycation End Products Improves Memory State in a Model of Alzheimer's Disease].
    Volpina OM; Koroev DO; Volkova TD; Kamynina AV; Filatova MP; Zaporozhskayva YV; Samokhin AN; Aleksandrova IJ; Bobkova NV
    Bioorg Khim; 2015; 41(6):709-16. PubMed ID: 27125025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization treatment approaches in Alzheimer's and prion diseases.
    Wisniewski T; Sigurdsson EM
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):400-4. PubMed ID: 12169219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid in Alzheimer's disease and prion-related encephalopathies: studies with synthetic peptides.
    Forloni G; Tagliavini F; Bugiani O; Salmona M
    Prog Neurobiol; 1996 Jul; 49(4):287-315. PubMed ID: 8888112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice.
    Bobkova NV; Medvinskaya NI; Kamynina AV; Aleksandrova IY; Nesterova IV; Samokhin AN; Koroev DO; Filatova MP; Nekrasov PV; Abramov AY; Leonov SV; Volpina OM
    Neurobiol Learn Mem; 2014 Jan; 107():50-64. PubMed ID: 24239620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Janus C; Pearson J; McLaurin J; Mathews PM; Jiang Y; Schmidt SD; Chishti MA; Horne P; Heslin D; French J; Mount HT; Nixon RA; Mercken M; Bergeron C; Fraser PE; St George-Hyslop P; Westaway D
    Nature; 2000 Dec 21-28; 408(6815):979-82. PubMed ID: 11140685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.
    Perovic S; Böhm M; Meesters E; Meinhardt A; Pergande G; Müller WE
    Mech Ageing Dev; 1998 Mar; 101(1-2):1-19. PubMed ID: 9593309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation.
    White AR; Maher F; Brazier MW; Jobling MF; Thyer J; Stewart LR; Thompson A; Gibson R; Masters CL; Multhaup G; Beyreuther K; Barrow CJ; Collins SJ; Cappai R
    Brain Res; 2003 Mar; 966(2):231-44. PubMed ID: 12618346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease.
    Vintém AP; Henriques AG; da Cruz E Silva OA; da Cruz E Silva EF
    Neurotoxicol Teratol; 2009; 31(2):85-8. PubMed ID: 19028567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prion-Like Properties of Amyloid-β Assemblies: Implications for Alzheimer's Disease.
    Walker LC; Schelle J; Jucker M
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.